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Center for Neuroscience and Department of Neurology, University of California, Davis, CaliforniaABSTRACT Using the substituted-cysteine-accessibility method, we previously showed that a cysteine residue introduced
to the Y512 position of CLC-0 was more rapidly modiﬁed by a negatively charged methanethiosulfonate (MTS) reagent, 2-sul-
fonatoethyl MTS (MTSES), than by the positively charged 2-(trimethylammonium)ethyl MTS (MTSET). This result suggests
that a positive intrinsic pore potential attracts the negatively charged MTS molecule. In this study, we further test this hypothesis
of a positive pore potential in CLC-0 and ﬁnd that the preference for the negatively charged MTS is diminished signiﬁcantly in
modifying the substituted cysteine at a deeper pore position, E166. To examine this conundrum, we study the rates of MTS
inhibitions of the E166C current and those of the control mutant current from E166A. The results suggest that the inhibition of
E166C by intracellularly applied MTS reagents is tainted by the modiﬁcation of an endogenous cysteine, C229, located at
the channel’s dimer interface. After this endogenous cysteine is mutated, CLC-0 resumes its preference for selecting MTSES
in modifying E166C, reconﬁrming the idea that the pore of CLC-0 is indeed built with a positive intrinsic potential. These
experiments also reveal that MTS modiﬁcation of C229 can inhibit the current of CLC-0 depending on the amino acid placed
at position 166.INTRODUCTIONCLC-0 from the electric organ of Torpedo rays is a voltage-
dependent Cl channel in the CLC channel/transporter
family (1 5). Although several CLC family members are
suggested to be Cl -Hþ antiporters (6 8), CLC-0 is a Cl
channel, with a Cl flux rate through the channel pore on
the order of 107 ions per second. The opening and closing
of the CLC-0 pore is controlled by two gating mechanisms,
termed the ‘‘fast-gating’’ and ‘‘slow-gating’’ mechanisms
(1,4,9). Though the relationship between the CLC-0 gating
mechanisms and the Cl -Hþ antiporter mechanism of the
bacterial CLC molecule (such as CLC-ec1) is not clear, the
structural architectures of all CLC proteins appear to be
conserved (3,4). For example, high-resolution structures of
bacterial CLCs show the obstruction of the Cl transport
pathway by a glutamate residue, E148 (10,11). Mutation of
the corresponding glutamate (E166) of CLC-0 to alanine
or glutamine results in a constantly open channel, leading
to the hypothesis that the negatively charged side chain of
this residue acts as the fast gate of CLC-0 (11).
In addition to the aforementioned conserved glutamate
residue, several lines of experiments also indicate that the
high-resolution structure of bacterial CLC molecules pro-
vides a good roadmap for studying eukaryotic CLC proteins.
Experiments employing fluorescence resonance energy trans-
fer (FRET) techniques suggested that the distance between the
C-terminal end of helix R in CLC-0 is comparable to that in
CLC-ec1 (12). Furthermore, cysteine modification experi-
ments using methanethiosulfonate (MTS) reagents also
showed a similarity in the structural architecture of CLC-
0 and bacterial CLCs (13 15). For example, MTS modifica-Submitted May 26, 2009, and accepted for publication September 24, 2009.
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0006 3495/10/02/0377/9 $2.00tion of cysteine residues along helix R of CLC-0 revealed
a helical pattern as shown by the bacterial CLC structure
(13). MTS modification experiments also showed that
compared to the positively charged reagent, the negatively
charged MTS was favored in the modification of the cysteine
introduced into the pore, as if the pore had an intrinsic positive
potential (13,15).
In the previous modification experiments using intracellu-
larly applied MTS reagents, the deepest probed position in the
CLC-0 pore was Y512 (13), a residue only 4 A˚ away from
E166 (10,11). Y512 and E166 appear to be in the narrowest
region of the pore, according to the bacterial CLC structure
(10,11). We recently used amphiphilic pore blockers,
such as parachlorophenoxy acetate (CPA) and octanoate
(Fig. 1 A), to block the CLC-0 pore and found that the side
chain of the residue at position 166 interacts with negatively
charged amphiphilic blockers (16). Accordingly, negatively
charged MTS reagents, such as 2-sulfonatoethyl MTS
(MTSES) and 5-sulfonatopentyl MTS (MTSPeS) (Fig. 1 A),
can also reversibly block the pore of E166C (Fig. 1, B
and C). On the other hand, a positively charged MTS reagent,
such as 2-aminoethyl MTS (MTSEA), does not show a
reversible block (Fig. 1 B). Surprisingly, the irreversible
current inhibition of the E166C mutant, presumably due to
cysteine modifications (17), is faster when MTSEA is used
as the modifying reagent. To solve this puzzle, we compared
the MTS modification rates of Y512C and E166C during
various pore manipulations. Further experiments revealed
that MTS reagents not only inhibited the E166C current,
they also reduced the current of the E166A mutant. These
results reveal a cytoplasmic cysteine residue at the dimer
interface whose modification by the MTS reagents reduces
the current of the channel depending on the residue placed
at the 166 position.doi: 10.1016/j.bpj.2009.09.066
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FIGURE 1 Negatively charged MTS reagents reversibly block the pore
of the E166C mutant. (A) Molecular structure of MTS reagents and
octanoate. (B) Comparison of the block of MTSES and MTSEA in the
E166C (upper panels) and Y512C (lower panels) mutants. Recording
traces were obtained by changing the voltage from 0 mV to þ80 mV,
and to 80 mV. Application of MTS reagents (3 mM for both MTSES
and MTSEA) via a fast solution exchange is indicated by the horizontal
bars (wash in and washout of MTS reagents are also indicated by arrows).
Notice that only the intracellular application of MTSES to the E166C
mutant at 80 mV shows a reversible current inhibition in response to
the fast solution exchange. (C) A longer, negatively charged MTS reagent
(MTSPeS) is more potent in reversibly blocking E166C than MTSES.
Notice that a lower concentration (1.2 mM) of MTSPeS generates a larger
degree of steady state block at 80 mV compared to the MTSES block
shown in B.
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Mutagenesis and channel expression
All CLC molecules consist of two identical subunits, each of which
contains a Cl transport pathway. In CLC 0, the fast gating mechanism
controls the individual protopore in the millisecond time range, whereas
the slow gating mechanism opens and closes the two protopores simulta
neously on a timescale of seconds (1,9). For convenience, we designed
the experiments so that the MTS modification rates would be in the range
of several seconds. Therefore, locking the slow gate of CLC 0 in the open
state simplified the data acquisition and analysis. For this purpose, we took
advantage of a point mutant, C212S, whose channel properties are identical
to those of the wild type (WT) channel, except for a locked open slow gate
(18). Except when indicated otherwise, all of the mutations were conBiophysical Journal 98(3) 377 385structed in the C212S mutation background, and the term ‘‘WT channel’’
refers to the C212S mutant. In the experiments illustrated in Fig. 5, we
mutated endogenous cysteines both in groups and individually to identify
the endogenous cysteine whose modification caused a functional conse
quence. Besides C212, there are 11 cysteine residues in the WT CLC 0
channel. The mutations were made using polymerase chain reaction muta
genesis approaches, and were confirmed by commercial DNA sequencing
services. All cDNAs were constructed in the pcDNA3 vector for expression
in human embryonic kidney (HEK) 293 cells. Transfection of cDNA into
HEK 293 cells was performed as described previously (13,15). Normally,
the experiments were performed 1 3 days after cDNAs were transfected
into the HEK 293 cells.Electrophysiological recordings
Macroscopic current recordings from the excised, inside out membrane
patches of HEK 293 cells were performed throughout the study, using
previously described methods (13,15). Briefly, the experiments were con
ducted with the use of an Axopatch 200B amplifier (Axon Instruments/
Molecular Devices, Union City, CA). The recording was digitally filtered
at 1 kHz and digitized at 2 kHz using a Digidata 1320 digitizing
board and pClamp8 software (Axon Instruments/Molecular Devices).
The recording pipettes were pulled from borosilicate glass (World Preci
sion Instruments, Sarasota, FL) using a vertical pipette puller (pp830;
Narishige International, New York, NY). Except when indicated other
wise, the standard pipette and the bath solutions contained (in mM)
130 NaCl, 5 MgCl2, 10 HEPES, 1 EGTA, pH 7.4. The pipette resistance
was ~2 4 MU. For certain experiments, the Cl concentration ([Cl ]) in
the bath solution was changed. In these experiments, MgCl2 was
replaced with MgSO4, and NaCl was replaced with NaGlu to make the
desired [Cl ].MTS modiﬁcations
MTS reagents (see Fig. 1 A) were purchased from Toronto Research Chem
icals (North York, Canada). The stock solution of 0.3 M was first made in
distilled water and then stored at 80C. An aliquot of stock solution was
placed on ice during the experiment. The working solutions containing the
required MTS reagents were made immediately before use and were dis
carded if they were not used within 5 min.
MTS reagents were applied to the intracellular side of the excised
membrane patches by means of an SF 77 solution exchanger (Warner
Instruments/Harvard Apparatus, Hamden, CT). The detailed modification
protocol was described previously (13). Briefly, the membrane potential
of the excised patch was clamped at particular voltages (VMO) for 1.4 s,
during which time the patch was exposed to the intracellularly applied
MTS reagent for 1 s. Following the 1.4 s voltage step of VMO, the voltage
was stepped to þ80 mV (VMN þ80 mV) for 100 ms to measure the
remaining current. This modification procedure was repeated every 2 s.
The time constant of the current inhibition process upon application of the
MTS reagent was used to determine the MTS modification rate (kMTS). The
current measured at þ80 mV at each recording sweep was normalized to
that measured right before the start of MTS modification, as shown in
Fig. 2 A. The MTS modification process was then fitted to a single expo
nential function. The time constant (tmo) and the concentration of MTS
reagents ([MTS]) were used to calculate the rate constant according to
the following equation:
kMTS ¼ 1=ðtmo  ½MTSÞ: (1)
For the purpose of presenting the averaged MTS modification process and
comparing the modification processes in different conditions, the current
inhibition process, except for those shown in Fig. 5, is plotted against the
accumulative exposure, i.e., concentration  time (with a unit of mM  s).
Averaged data are presented as the mean5 SE (n 3 6).
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FIGURE 2 Comparison of the rate of
modification of Y512C to that of
E166C by MTSES and MTSEA. (A)
Time course of the modification of
Y512C (left panel) and E166C (right
panel) by intracellularly applied MTSES
(solid symbols) and MTSEA (open
symbols). Excised inside out patch
recordings are shown; VMO (duration
1400 ms) 40 mV, and VMN (duration
100 ms) 80 mV. MTS reagents were
applied as indicated by the downward
arrows. The current amplitudes
measured at VMN from the recording
traces were normalized to that obtained
just before the application of MTS
reagents. (B) Modification rates of
Y512C and E166C by MTSES (solid
squares) and MTSEA (open circles) at
voltages from 80 mV to þ 40 mV.
The second order rate constant was
calculated from the measured time
constant of the current inhibition course
according to Eq. 1. Upper panels are
modification rates at different voltages.
Lower panels show the ratio of kMTSES/
kMTSEA at various modification voltages.
(C) Effects of K519 mutations on the
MTS modification rates of Y512C and
E166C. Upper panels are MTSES (solid
bars) and MTSEA (open bars) modifica
tion rates at VMO 40 mV. Lower
panels show the ratio of kMTSES/kMTSEA.
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Negatively charged MTS reagents reversibly block
E166C but not Y512C
Negatively charged pore blockers, such as CPA and fatty
acids, are known to block CLC-0 reversibly. The blocking
affinity of these amphiphilic compounds is increased dramat-
ically if the residue E166 is replaced with a residue contain-
ing a small and/or hydrophobic side chain. For example,
the apparent half-blocking affinity (K1/2) of octanoate for
the WT pore is ~0.7 mM at 80 mV, whereas the K1/2 of
octanoate for the E166C mutant is ~0.02 mM at the samevoltage (16). On the other hand, the amphiphilic blocker
with a shorter hydrophobic chain blocks E166C with a
lower affinity the K1/2 of butyrate for the E166C mutant
is >1 mM at 80 mV (16).
MTSES and MTSPeS both contain a negatively charged
sulfonate on one end of the molecule. The rest of the mole-
cule is an aliphatic-thiol chain ended with a methane thiol
group (Fig. 1 A). It is therefore expected that these two
compounds can reversibly block E166C, although their
blocking affinities may be lower than that of octanoate
because the aliphatic chain in fatty acids is more hydro-
phobic compared to the methane thiol group of MTSBiophysical Journal 98(3) 377 385
380 Zhang et al.reagents. Fig. 1, B and C, show that both MTSES and
MTSPeS reversibly block the E166C mutant (indicated by
arrows) at negative voltages, but not at positive voltages.
On the other hand, the positively charged MTS reagent,
MTSEA, does not produce a reversible block in E166C.
Furthermore, because MTSPeS has a longer hydrophobic
chain than MTSES (Fig. 1 A), the off-rate of the former is
much slower than that of the latter, resulting in a higher
steady-state blocking affinity for MTSPeS in blocking the
pore of E166C. These results are consistent with our previ-
ously proposed blocking mechanism for amphiphilic mole-
cules in CLC-0 (16).MTSES and MTSEA irreversibly inhibit the current
of E166C and Y512C
In addition to the reversible block described above, MTSES,
as well as the positively charged reagent MTSEA, also irre-
versibly inhibits the current of the Y512C and E166C mutant
channels (Fig. 2 A), presumably due to the modification of
the cysteine residues on the channel. However, these two
mutant channels have different preferences in favoring nega-
tively or positively charged MTS molecules. At negative
voltages the MTSES modification rate of Y512C is faster
than that of MTSEA, whereas in the E166C mutant the pref-
erence of MTSES over MTSEA is reversed: the MTSES
modification is slower than the MTSEA modification.
Furthermore, the MTSES modification rate of Y512C is
voltage-dependent, whereas the voltage dependence of the
MTSES and MTSEA modifications in E166C is negligible.
Therefore, the ratio of the MTSES and MTSEA modification
rates (kMTSES/kMTSEA) ranges from ~0.5 to ~8 (from þ40 mV
to 80 mV) in Y512C, whereas the kMTSES/kMTSEA for
E166C remains quite constant (~0.06) in the same voltage
range (Fig. 2 B). Because the intrinsic reactivity of MTSEA
is ~50-fold higher than that of MTSES, these results appear
to suggest that the pore of the Y512C mutant channel favors
the MTSES molecule, and this preference is greatly reduced
in the E166C mutant (see Discussion).
The observation that Y512C, but not E166C, has a prefer-
ence for a negatively charged MTS reagent over a positively
charged MTS reagent is surprising because the positions of
these two residues are both deep in the pore, separated by
merely 4 A˚. If the intrinsic potential is critical in determining
the accessibility of the pore to charged MTS reagents
(13,15), these two mutants should have a similar kMTSES/
kMTSEA ratio. Previous studies revealed that two charged
residues, K519 and E127, are critical for the channel conduc-
tance, possibly due to its electrostatic control of the intrinsic
potential at the intracellular pore entrance (13,19,20). We
therefore tested the effect of K519/E127 mutations on the
MTS modification in Y512C and E166C. Consistent with
previous studies, the kMTSES/kMTSEA ratio of Y512C indeed
depends on the charge at position 519 the ratio decreases
with a less positive charge at this position (Fig. 2 C, left).Biophysical Journal 98(3) 377 385This electrostatic effect is suppressed by a simultaneous
E127Q mutation (data not shown). On the other hand, the
kMTSES/kMTSEA ratio for the E166C modification is not
affected by K519 mutations (Fig. 2 C, right). The kMTSES/
kMTSEA ratio of the E166C mutant remains the same whether
a positively charged lysine or a negatively charged glutamate
is located at this position.
Pore manipulations affect the MTSESmodiﬁcation
of Y512C but not E166C
The negligible effect of K519 mutations on the E166C
modification led us to suspect that the irreversible current
inhibition of E166C by MTS reagents may not be due to
the modification of the introduced cysteine at position 166.
If the modification indeed occurs in the pore, we would
expect the pore manipulations to affect the modification
in a predicted manner. Accordingly, we further tested the
MTSES modifications in Y512C and E166C under two
manipulations: altering the intracellular Cl concentration
([Cl ]i) and blocking the pore with CPA, a CLC-0 pore
blocker (16,21). Fig. 3, A and B show that increasing
[Cl ]i reduces the MTSES modification rate in Y512C but
not in E166C. Similarly, intracellular application of 3 mM
CPA to block the channel also reduces the MTSES modifica-
tion rate in Y512C but not in E166C. Because Cl and CPA
are known to enter the pore, the presence of Cl and CPA is
likely to compete with the modifying MTSES molecule and
reduce the MTSES modification rate. However, neither pore
manipulation affects the MTSES modification rate of E166C
in a predicted manner. These results suggest that perhaps the
modification of an endogenous cysteine contributes to the
current inhibition of E166C.
MTS reagents irreversibly inhibit the E166A
mutant
If the inhibition of the current of E166C by MTS modification
is not due purely to the modification of cysteine at position
166, MTS reagents may still be able to irreversibly inhibit
E166 mutants other than E166C. Even though the MTS
reagents produce very little effect when the WT residue gluta-
mate is at position 166 (Fig. 4 A), this possibility cannot be
excluded when other amino acids are placed at this position.
Accordingly, we compared the MTSES and MTSEA modifi-
cations of E166A to those of the E166C mutant (Fig. 4, B
and C). It can be seen that both MTSES and MTSEA
are able to irreversibly inhibit E166C and E166A mutants.
The MTSES modification rate is only slightly reduced in
the E166A mutant compared to that of E166C, whereas the
MTSEA modification rates in the E166C and E166A mutants
are nearly the same. These results clearly demonstrate that
modification of an endogenous cysteine is responsible for
the irreversible inhibition of E166A by MTS reagents, sug-
gesting that the MTS modification rate of E166C may be
tainted by the modification of the endogenous cysteine.
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FIGURE 3 Inhibition of Y512C by MTSES is mostly due to modification
activity in the pore, but modification of E166C may include a cysteine modi
fication outside the pore. (A) The MTSES modification time course of Y512C
depends on [Cl ]i. Numbers represent [Cl ]i (in mM) in each modification.
Inset: MTSES modification rate of Y512C as a function of [Cl ]i. The solid
curve is the best fit to a hyperbolic equation: kMTSES P2 þ (P1 P2)/
(1þ [Cl ]/K1/2), withP1 8605 M 1s 1,P2 181 M 1s 1, and an apparent
half effective Cl concentration (K1/2) of 33 mM. (B) MTSES modification
rates of Y512C (left) and E166C (right) in two [Cl ]i. (C) Intracellular pore
blocker reduces kMTSES of Y512C but increases that of E166C.
Cysteine Modiﬁcation in CLC-0 381Modiﬁcation of C229 is responsible for the MTS
inhibition of E166A
To search for the endogenous cysteine, we constructed muta-
tions of endogenous cysteine residues in the background of
the E166A mutation. We used MTSEA to explore the modi-
fication because MTSEA had a more robust irreversible inhi-
bition on E166A than MTSES. Fig. 5 A shows our initial
screen, in which a mutant construct may contain multiple
cysteine mutations. It can be seen that the mutant channel
containing three cysteine mutations (C212A, C213A, and
C229S) is resistant to the MTSEA-induced current inhibi-
tion. Because the E166A mutant in the WT background
referred to in this study (containing the C212S mutation) is
inhibited by MTSEA, the target could only be C213 or
C229. As can be seen from Fig. 5 B, although the C213A/
C212S double mutant is still sensitive to MTSEA modifica-
tion, the C229S/C212S mutant is resistant to MTSEAmodification. We conclude that the modification of C229
is responsible for the MTS inhibition in the E166A mutant,
and this modification could also contribute to the irreversible
inhibition of the E166C current.C229S mutation resumes a higher MTSES
accessibility in modifying E166C
As shown in Fig. 4,B andC, replacing cysteine with alanine at
position 166 only slightly reduced the MTSES modification
rate, and had no effect on the MTSEA modification rate.
We suspected that the MTS modification of C229 must
significantly contribute to the MTS-induced current inhibition
of E166C. To evaluate more precisely the modification rate of
the cysteine at position 166, we modified the E166C mutant in
the background of the C229S mutation. As shown in Fig. 6,
both MTSES (Fig. 6 A) and MTSEA (Fig. 6 B) can still
irreversibly inhibit the E166C/C229S mutant. On the other
hand, both MTSES and MTSEA have very little effect on
the E166A/C229S mutant. For the E166C/C229S mutant,
neither the charge mutation (K519M) at the pore entrance
(Fig. 6 C) nor the change of the membrane voltage (Fig. 6 D)
alters the MTS modification rates. The MTSES modifica-
tion rate of E166C/C229S is not significantly different from
that of E166C (shown in Fig. 4). However, the MTSEA modi-
fication rate of E166C/C229S is reduced by removing the
MTS modification target at position 229. The resulting
kMTSES/kMTSEA ratio in the E166C/C229S mutant is ~0.7.
Because the intrinsic reactivity of MTSEA is>50-fold higher
than that of MTSES, a kMTSES/kMTSEA ratio of 0.7 reflects
a higher accessibility of MTSES over MTSEA by ~35-fold
in reaching the cysteine at the 166 position.DISCUSSION
This study was motivated by the observation that the ratios of
the MTSES and MTSEA modification rate constants,
kMTSES/kMTSEA, are very different for the cysteine at two
nearby positions in the CLC-0 pore, namely, Y512C and
E166C. The kMTSES/kMTSEA ratio for a pore cysteine can
reflect the intrinsic electrostatic potential in the channel
pore (13,22,23). It has been reported that the reaction rates
of MTSEA and MTSES with b-mercaptoethanol in aqueous
solutions are ~5  105 M 1s 1 and 104 M 1s 1, respec-
tively, suggesting that the intrinsic reactivity of MTSEA is
~50-fold greater than that of MTSES (24). Thus, a kMTSES/
kMTSEA ratio of 1 may reflect a 50-fold accessibility advan-
tage for the negatively charged MTSES molecule over the
positively charged MTSEA molecule. Our results show
that the kMTSES/kMTSEA ratio of the Y512C modification is
0.5 8 within the voltage range of þ40 mV to 80 mV, indi-
cating that MTSES is favored by 25- to 400-fold over
MTSEA in reaching the cysteine at the Y512 position. On
the other hand, the kMTSES/kMTSEA ratio of E166C has
a constant value of ~0.06 within the tested voltage range,Biophysical Journal 98(3) 377 385
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FIGURE 4 Comparison of the MTSES and MTSEA
modification rates of CLC 0 in which (A) glutamate, (B)
cysteine, and (C) alanine are located at position 166.
Downward arrows indicate the beginning of the application
of MTS reagents.
382 Zhang et al.suggesting that the preference of MTSES over MTSEA is
greatly lost in modifying this mutant channel. Because
E166 and Y512 are very close to each other in the pore
(within a distance of only 4 A˚), it is quite surprising thatA B
Biophysical Journal 98(3) 377 385the kMTSES/kMTSEA ratios of E166C and Y512C differ from
each other so dramatically.
Because altering charged residues in the pore region did
not affect the modification pattern of E166C by MTSESFIGURE 5 Searching for the endogenous cysteine
responsible for the current inhibition caused by MTS modi
fications. All cysteine mutants were constructed in the
background of the E166A mutation. MTSEA is 300 mM
in all panels, which depict the experiments in single
patches. (A) Examples of MTSEA modifications of
cysteine removed mutants of CLC 0. The 12 endogenous
cysteine residues are divided into four groups, each of
which encompasses three cysteine residues. All three
cysteine residues are removed simultaneously for the first
three groups, and the individual cysteine residue is mutated
one by one for the fourth group. MTSEA was applied as
indicated by the arrows. (B) Searching for the cysteine
residue in group 3 responsible for the lack of inhibition
by the MTSEA modification.
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FIGURE 6 Comparison of the MTSES and MTSEA
modification rates in the E166C/C229S related mutants.
(A and B) Current inhibition course of the E166C/C229S
mutant by MTSES (A) and MTSEA (B). For comparison,
MTS modifications of E166A/C229S are also shown. (C)
Averaged MTSES (solid bars) and MTSEA (open bars)
modification rates of the E166C/C229S (labeled as K519)
and E166C/C229S/K519M (labeled as K519M) mutants.
(D) Averaged MTSES modification rates of the E166C/
C229S mutant at four voltages.
Cysteine Modiﬁcation in CLC-0 383and MTSEA (Fig. 2 C), we suspected that the MTS-induced,
irreversible current inhibition of E166C might not be due
purely to the modification in the pore. We thus tested the
effects of two manipulations on the MTS modification rates:
varying [Cl ]i and blocking the pore with CPA (Fig. 3). Both
Cl and CPA carry a negative charge and can enter the pore
of CLC-0. The occupancy of the pore with Cl or CPA
should inhibit the binding of the negatively charged MTSES
in the pore and thus reduce the MTSES modification rate.
This expectation was valid in Y512C but not in E166C.
Furthermore, MTS reagents still irreversibly inhibited the
current of the E166A mutant (Fig. 4 C). This latter observa-
tion indicates that MTS modification of an endogenous
cysteine causes the irreversible current inhibition in the
E166A mutant.
By testing whether MTSEA modification can reduce the
current in various cysteine mutants, we were able to deter-
mine that C229, which is located at the loop between helix
H and helix I at the dimer interface of CLC-0, can be
modified by MTS reagents (Fig. 5). However, the electro-
physiological approach can only report a cysteine whose
modification leads to a functional consequence. Therefore,
we cannot rule out the modification of other endogenous
cysteines by intracellularly applied MTS reagents. Nonethe-
less, modification of C229 by MTS reagents can lead to
a current reduction in the E166A mutant. The C229 modifi-
cation also appears to contribute to the current reduction of
the E166C mutant, as can be seen by comparing the currents
after MTS modification of E166C to that of the E166C/
C229S double mutant eliminating the cysteine at position
229 reduces both the MTSES and MTSEA modification
effects (Fig. 6). Because modification of C229 contributes
to the current inhibition, the current inhibition of E166C
reflects at least the summation of the modification of cysteineresidues at positions 166 and 229. On the other hand, the
modification of the E166C/C229S mutant should represent
a better estimate of the modification rate of the cysteine at
position 166. The kMTSES/kMTSEA ratio of the E166C/C229S
mutant is ~0.7, a value that reflects a ~35-fold selection of
MTSES over MTSEA in accessing the cysteine residue at
position 166. These results indeed support the hypothesis
that the pore of CLC-0 has a positive intrinsic potential.
It is interesting that MTS modification of C229 appears to
have little effect in reducing the current when a glutamate
residue is at position 166 (Fig. 4 A). Thus, the functional
consequence of modifying a cysteine at the dimer interface
depends on a residue in the pore. We suspect that this could
come from an allosteric structural communication between
the pore region near residue 166 and the region near C229
at the dimer interface. A recent study by Osteen and Mindell
(25) also suggested an allosteric communication between
residue 166 and an extracellular Zn2þ-binding site in CLC-4
through the movement of helix N. It will be interesting to
further explore the movement transmitted from the dimer
interface to the pore region, a possible mechanism under-
lying the slow-gating mechanism of CLC-0 (12).
One difference between Y512C and E166C is that the
MTSES modification of the former is much more voltage-
dependent. The voltage dependence is expected if the Cl
occupancy in the pore is less at more negative membrane
potentials (26,27) and/or if the binding of the negatively
charged MTSES molecule to the pore follows the Wood-
hull-type voltage-dependent mechanism (28). However,
these explanations alone cannot explain the difference in
voltage dependence between the E166C and Y512C modifi-
cations. It should be noted that the off-rate of MTSES
(or MTSPeS) is likely much smaller in the E166C pore
than in the Y512C pore because the side chain of cysteineBiophysical Journal 98(3) 377 385
FIGURE 7 Hypothetical diagram depicting the position of the MTSES
molecule with respect to the three pore residues when Y512C (left) or
E166C (right) is modified. Only one pore of the double barreled channel
is shown. The extracellular end of the pore is on top. Scen and Sint respec
tively represent the central and internal Cl binding sites observed in the
bacterial CLC molecule. Because the side chain of the residue at position
166 (whether it is glutamate or cysteine (21)) does not allow the punch
through of MTSES, the location of the bound MTSES does not easily allow
the MTS end to reach the thiol group at position 166 (dotted curved arrow
on the right panel). On the other hand, the orientations of the MTS group and
the thiol at position 512 should help the reaction occur more easily (solid
curved arrow on the left panel).
384 Zhang et al.at position 166, compared to that of glutamate (in the Y512C
mutant), has a tighter interaction with MTS molecules (16).
Yet, the absolute MTSES modification rate of Y512C is
larger than that of the E166C mutant, at least in the negative
voltage range (Fig. 2 B). We suspect that the sluggish rate of
modifying E166C is the result of structural constraints in the
pore. Because the side chain of the amino acid (other than
glycine) at position 166 prevents the punch-through of the
MTS molecule (21), residue 166 is likely to be the deepest
position that intracellularly applied MTS reagents can reach.
Fig. 7 depicts our vision of the bound MTSES molecule in
the pore. It is quite straightforward to see that such a location
of the bound MTSES molecule would make it more difficult
for the MTS reactive sulfur to closely contact the thiol group
of the cysteine at position 166 than to react with the cysteine
thiol group at the 512 position. This likely creates a rate-
limiting step for MTS reagents to modify E166C because
altering the charge at the pore entrance (Fig. 6 C) or changing
the voltage (Fig. 6 D) although significantly altering the
on- and off-rates of the binding of MTSES molecules to
the pore (16) does not affect the MTS modification rate
of E166C. Thus, even though the reversible MTSES binding
to the E166C pore has a higher affinity at more negative
potential, the limitation in the final reaction step curtails
the success of the modification.
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